Glycolytic key enzymes such as hexokinase 2 (HK2), phosphofructosidase (PFK), and M2-type acetone kinase (PKM2) are tumor markers, and their expression and activity can affect tumor glycolysis, which in turn affects proliferation of tumor cells13–17. Here, HK2 is linked to neoplasm.